HINGE HEALTH INC-A

HNGENYSE

🏆 #942 by market capEarnings Nov 3US Equity

$89.01▼ $2.49 (−2.80%)

🌅 Pre-market$90.94▲ 2.17%Regular close · extended-hours price shown

1h—

24h▼ 2.8%

7d▲ 10.3%

14d▲ 20.1%

30d▼ 1.1%

1y▲ 59.4%

🏦Market Cap

$6.89B

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

80.8%

High

💵FCF Margin

31.4%

Strong

⚖️P/S Ratio

11.6x

Elevated

Otter Score

Fair

Trading Snapshot

Day Range: $88.01 – $90.29
52-Week Range: $30.08 – $92.89
Volume: $2.47B
Avg Volume: $3.06B
Shares Outstanding: 77.4M
Next Earnings: Sep 30, 2026

Fundamentals Snapshot

Annual Revenue: $588M
Last Q Revenue: $213M
P/E Ratio: —
P/S Ratio: 11.6x
EPS (TTM): $-12.30
Dividend Yield: —

Why Investors Own HNGE

✓High-growth profile — revenue up -5.3% YoY with expanding US Equity exposure.
✓Healthy economics — 76% gross margin and 11% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$588M▼ −8.6% YoY

Gross Margin (TTM)

76.0%▲ +2.0% YoY

Operating Income (TTM)

$136M▼ −8.6% YoY

Free Cash Flow (TTM)

$67M▼ −8.6% YoY

About HINGE HEALTH INC-A

Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.

🦦